Iridex (IRIX) Notes Payables (2011 - 2024)
Iridex's quarterly Notes Payables came in at $1.7 million in Q4 2024, up 31.96% quarter-over-quarter from $1.3 million in Q3 2024.
Iridex has reported Notes Payables for 7 years, with the latest figure at $1.7 million in Q4 2024.
- For the quarter ending Q4 2024, Notes Payables changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2024 stood at $1.7 million (changed N/A YoY), and the FY2024 full-year result was $1.7 million, changed N/A from the prior year.
- Notes Payables for Q4 2024 stood at $1.7 million, up from $1.3 million in the prior quarter.
- The five-year high for Notes Payables was $1.7 million in Q4 2024, with the low at $1.3 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2024 | 1.73 Mn |
| Sep 28, 2024 | 1.31 Mn |
| Dec 30, 2017 | 509,000.00 |
| Dec 31, 2016 | 496,000.00 |
| Jan 2, 2016 | 336,000.00 |
| Jan 3, 2015 | 500,000.00 |
| Dec 28, 2013 | 200,000.00 |
| Dec 29, 2012 | 158,000.00 |
| Dec 31, 2011 | 117,000.00 |